⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12967691 | 0.84 | — | — | |
| SCHEMBL4949941 | 0.82 | LMNA (0.44) | — | |
| SCHEMBL4952250 | 0.82 | — | — | |
| SCHEMBL13857611 | 0.82 | — | — | |
| SCHEMBL15326600 | 0.82 | — | — | |
| SCHEMBL12967583 | 0.79 | — | — | |
| SCHEMBL15291832 | 0.79 | — | — | |
| SCHEMBL1728130 | 0.76 | — | — | |
| SCHEMBL1684311 | 0.76 | — | — | |
| SCHEMBL7869634 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114824092-B | Solar cell based on quasi-two-dimensional perovskite and preparation method thereof | 北京炎和科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| WO-2017205191-A1 | INSULIN RECEPTOR PARTIAL AGONISTS AND GLP-1 ANALOGUES | MERCK SHARP & DOHME CORP. (US) | 2017-11-30 | — | — | WO | disclosed |
| WO-2016205367-A1 | METHODS FOR THE TREATMENT OF LEPTOMENINGEAL CARCINOMATOSIS | ANGIOCHEM INC. (CA) | 2016-12-22 | — | — | WO | disclosed |
| WO-2016205488-A1 | MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF | THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2016-12-22 | — | — | WO | disclosed |
| WO-2016081670-A2 | INSULIN RECEPTOR PARTIAL AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2016-05-26 | — | — | WO | disclosed |
| US-20080146768-A1 | PROCESSES FOR PREPARING POLYMERS USING ALPHA,OMEGA-DIFUNCTIONAL ALDARAMIDES | E. I. DU PONT DE NEMOURS AND COMPANY | 2008-06-19 | — | — | US | disclosed |
| CN-101163731-A | Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers | DU PONT (US) | 2008-04-16 | — | — | CN | disclosed |
| EP-1858955-A1 | PROCESSES USING ALPHA, OMEGA-DIFUNCTIONAL ALDARAMIDES AS MONOMERS AND CROSSLINKERS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-11-28 | — | — | EP | disclosed |
| US-20060264672-A1 | Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-11-23 | — | — | US | disclosed |
| WO-2006091901-A1 | PROCESSES USING ALPHA, OMEGA-DIFUNCTIONAL ALDARAMIDES AS MONOMERS AND CROSSLINKERS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-08-31 | — | — | WO | disclosed |